Mycapssa الاتحاد الأوروبي - اللاتفية - EMA (European Medicines Agency)

mycapssa

amryt pharmaceuticals dac - octreotide acetate - akromegālija - hipofīzes un hipotalāma hormoni un analogi - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.